Trial
NCT03203304
Stereotactic Body Radiotherapy (SBRT) Followed by Immunotherapy in Liver Cancer
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Chicago
Collaborators
—
Condition
Hepatocellular Carcinoma
Intervention
Nivolumab
Why stopped
Study stopped due to poor accrual.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-06-10